Evidence map›Paper›PMID 38858606›Full record

ArticleNature aging2024

Estrogen counteracts age-related decline in beige adipogenesis through the NAMPT-regulated ER stress response.

Jooman Park, Ruoci Hu, Yanyu Qian, Shaolei Xiong, Asma Sana El-Sabbagh, Meram Ibrahim, Jaden Wang, Ziqiao Xu, Zhengjia Chen, Qing Song and 9 more

Abstract read
In one paragraph

Article in Nature aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Jooman Park *Department of Physiology and Biophysics, College of Medicine, University of Illinois Chicago, Chicago, IL, USA.
Ruoci Hu *Department of Physiology and Biophysics, College of Medicine, University of Illinois Chicago, Chicago, IL, USA.
Yanyu QianDepartment of Physiology and Biophysics, College of Medicine, University of Illinois Chicago, Chicago, IL, USA.
Shaolei XiongDepartment of Physiology and Biophysics, College of Medicine, University of Illinois Chicago, Chicago, IL, USA.
Asma Sana El-SabbaghDepartment of Physiology and Biophysics, College of Medicine, University of Illinois Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-5635-9755
Meram IbrahimDepartment of Physiology and Biophysics, College of Medicine, University of Illinois Chicago, Chicago, IL, USA.
Jaden WangDepartment of Physiology and Biophysics, College of Medicine, University of Illinois Chicago, Chicago, IL, USA.
Ziqiao XuDivision of Epidemiology and Biostatistics, School of Public Health, University of Illinois Chicago, Chicago, IL, USA.
Zhengjia ChenDivision of Epidemiology and Biostatistics, School of Public Health, University of Illinois Chicago, Chicago, IL, USA.
Qing SongDepartment of Kinesiology and Nutrition, University of Illinois Chicago, Chicago, IL, USA.
Zhenyuan SongDepartment of Kinesiology and Nutrition, University of Illinois Chicago, Chicago, IL, USA.
Gege YanDepartment of Pharmacology and Regenerative Medicine, College of Medicine, University of Illinois Chicago, Chicago, IL, USA.
Abeer M MahmoudDivision of Endocrinology, Department of Medicine, University of Illinois Chicago, Chicago, IL, USA.
Yanlin HePennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, USA.ORCID http://orcid.org/0000-0002-5471-9016
Brian T LaydenDivision of Endocrinology, Department of Medicine, University of Illinois Chicago, Chicago, IL, USA.
Jiwang ChenDivision of Pulmonary, Critical Care, Sleep & Allergy, Department of Medicine, University of Illinois Chicago, Chicago, IL, USA.
Sang-Ging OngDepartment of Pharmacology and Regenerative Medicine, College of Medicine, University of Illinois Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0003-0182-8769
Pingwen XuDivision of Endocrinology, Department of Medicine, University of Illinois Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0001-9363-4114
Yuwei JiangDepartment of Physiology and Biophysics, College of Medicine, University of Illinois Chicago, Chicago, IL, USA. yuweij@uic.edu.ORCID http://orcid.org/0000-0002-5082-8012

Funding

Pilot and Feasibility ProgramP30DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI Raghavendra G Mirmira · 2013 to 2026
$20.9M
Regulation of beige adipocyte maintenance and its impact on metabolic outcomesR01DK132398 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Yuwei Jiang · 2022 to 2026
$2.6M
Testosterone and estrogen signaling pathways in the medial amygdala interact to control energy homeostasisR01DK123098 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI XU, PINGWEN · 2020 to 2024
$2.5M
Rab GTPases-mediated mitochondrial clearance in diabetic cardiomyopathyR01HL148756 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ONG, SANG GING · 2020 to 2024
$2.4M
Molecular regulation of adipose tissue development, homeostasis and expansionK01DK111771 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI JIANG, YUWEI · 2016 to 2021
$705k
Follicular and endometrial pathology in polycystic ovary syndromeK01OD011177 · OD · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI NEWELL-FUGATE, ANNE ELIZABETH · 2012 to 2015
$373k
Regulation of adipose lineage plasticity in obesityR03DK127149 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI JIANG, YUWEI · 2021 to 2022
$240k
NHLBI NIH HHS R01 HL148756NIDDK NIH HHS K01 DK111771NIDDK NIH HHS P30 DK020595NIDDK NIH HHS R01 DK123098NIDDK NIH HHS R01 DK132398NIDDK NIH HHS R03 DK127149NIH HHS K01 OD011177U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL148756U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) P30DK020595U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) R01DK123098U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) R01DK132398U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) R03DK127149
6 · The paper itself

Abstract

Thermogenic beige adipocytes are recognized as potential therapeutic targets for combating metabolic diseases. However, the metabolic advantages that they offer are compromised with aging. Here we show that treating mice with estrogen (E2), a hormone that decreases with age, can counteract the age-related decline in beige adipogenesis when exposed to cold temperature while concurrently enhancing energy expenditure and improving glucose tolerance in mice. Mechanistically, we found that nicotinamide phosphoribosyl transferase (NAMPT) plays a pivotal role in facilitating the formation of E2-induced beige adipocytes, which subsequently suppresses the onset of age-related endoplasmic reticulum (ER) stress. Furthermore, we found that targeting NAMPT signaling, either genetically or pharmacologically, can restore the formation of beige adipocytes by increasing the number of perivascular adipocyte progenitor cells. Conversely, the absence of NAMPT signaling prevents this process. Together, our findings shed light on the mechanisms regulating the age-dependent impairment of beige adipocyte formation and underscore the E2-NAMPT-controlled ER stress pathway as a key regulator of this process.

Indexed as

Adipocytes, BeigeAdipogenesisAgingEndoplasmic Reticulum StressEstrogensNicotinamide PhosphoribosyltransferaseAnimalsCytokinesEnergy MetabolismFemaleMiceMice, Inbred C57BLSignal TransductionCytokinesEstrogensNicotinamide Phosphoribosyltransferasenicotinamide phosphoribosyltransferase, mouse

Identifiers

PMID38858606
PMCPMC11829733

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.